marijuana stocks

Form 8-K for VERDE SCIENCE, INC.


27-May-2015

Change in Directors or Principal Officers

Item 5.02. Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.On May 19, 2015, the Board of Directors elected David Alexander to be the Chief Financial Officer of the Company.

David Alexander, CA, BComm – Chief Financial Officer

Mr. Alexander is a chartered accountant who graduated from the University of British Columbia with a BComm in Finance. He has managed the rapid growth of several early stage startup companies. As CFO of the start-up Nortran Pharmaceuticals, Inc., a University of British Columbia based pharmaceutical research and development company engaged in the development and commercialization of cardiovascular therapies, he assisted in obtaining its initial financing and first discoveries. While CFO of Arakis Energy Corporation, Mr. Alexander managed its growth from startup to over a billion dollars in assets, and moved its public company listing from the Vancouver Stock Exchange to Nasdaq in New York. Arakis was an international oil and gas development company with wells in Kentucky, Oman, New Guinea and the Sudan. The company was subsequently sold to Talisman Energy Inc. During his tenure as CFO and controller at Columbia Trust Company, Mr. Alexander managed the growth of its assets from $50 million to over $1 billion during a 5-year period. David left Columbia Trust when it was sold to a Toronto based trust company.

2

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PMCB to Attend J.P. Morgan Healthcare Conference

PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference  PharmaCyte Biotech, Inc. (PMCB),…

$IMLFF Files Provisional Patent Covering Novel Compounds for Treating

InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa…

$ZDPY to Launch Corporate Social Responsibility Program

Zoned Properties to Launch Corporate Social Responsibility Program Zoned Properties, Inc. (ZDPY)…

$PMCB Cancer Treatment Shows “Complete Tumor Remission”

PharmaCyte Biotech’s Cancer Treatment Shows “Complete Tumor Remission” in Published Preclinical Study…